Pathomation

Advancing Anatomical Pathology to the next level BioAnalytica is proud to be part of discussions focused on redefining the future of Anatomical Pathology. #DigitalPathology #Healthcare #Innovation #BioAnalytica #AnatomicalPathology

𝗪𝗵𝗮𝘁 𝘄𝗶𝗹𝗹 𝗱𝗲𝗳𝗶𝗻𝗲 𝘁𝗵𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀 𝗼𝗳 𝗜𝗛𝗖 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗼𝗻 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝟱 𝘆𝗲𝗮𝗿𝘀? The real bottleneck today is the ability to 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗲 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗶𝗻𝘁𝗼 𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝘁 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗲𝘃𝗲𝗿𝘆 𝗽𝗮𝘁𝗶𝗲𝗻𝘁, 𝗲𝘃𝗲𝗿𝘆𝘄𝗵𝗲𝗿𝗲, 𝗲𝘃𝗲𝗿𝘆 𝘁𝗶𝗺𝗲. Not more biomarkers or more data, but pathologists that are confident to score. And that’s a training challenge. Digital pathology is creating a new foundation:  • Hands-on learning with real cases  • Remote and scalable training programs  • Better alignment between pharmaceutical trials, and the real world in diagnostic labs We highlighted 11 resources that are already moving in this direction: https://lnkd.in/grZd-uHm This is where CDx, education, and digital pathology truly come together. 𝗛𝗼𝘄 𝗱𝗼 𝘆𝗼𝘂 𝘀𝗲𝗲 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘁𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗶𝗻 𝘆𝗼𝘂𝗿 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻? #Realworldevidence #Precisionmedicine #Biomarkers #Training

𝗠𝗮𝗸𝗶𝗻𝗴 𝗔𝗜 𝘂𝘀𝗮𝗯𝗹𝗲 𝗶𝗻 𝗱𝗮𝗶𝗹𝘆 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀 𝗶𝘀 𝘀𝘁𝗶𝗹𝗹 𝘃𝗲𝗿𝘆 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗶𝗻𝗴. Many labs struggle with:  • complex IT integrations  • validating new algorithms  • connecting AI tools with existing systems These barriers slow down the adoption of AI in pathology. Pathomation’s AI Marketplace helps remove those blockers. Labs can validate, compare, and run AI algorithms directly within their digital pathology workflow. Because AI creates the most value when it fits naturally into the pathologist’s routine. Find more info on our approach here: https://lnkd.in/eh9HU95A #AI #PDL1 #HER2 #ER #PR #KI67

𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗼𝗻 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗵𝗮𝘃𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗲𝗱 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆. But to realize their full benefit on patient therapy there is a critical factor: 𝗗𝗼 𝗮𝗹𝗹 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗵𝗮𝘃𝗲 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗳𝗮𝘀𝘁 𝗮𝗻𝗱 𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘁𝗲𝘀𝘁𝗶𝗻𝗴? In practice, CDx testing is much more than running an assay. It requires 𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝘁, 𝗵𝗶𝗴𝗵-𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝘀𝗰𝗼𝗿𝗶𝗻𝗴 𝗯𝘆 𝘁𝗿𝗮𝗶𝗻𝗲𝗱 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀. And that’s exactly where things often fall short.  • Training is fragmented and it is difficult to reach all pathologists  • Adoption of new CDx biomarkers progresses slowly due to the learning curve of labs and pathologists  • Interpretation variability remains a challenge At the same time, we now have something powerful: 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆. It enables hands-on learning with real cases, scalable training, and global access to expertise. In our most recent blog post, we’ve curated 𝟭𝟭 𝗼𝗳 𝘁𝗵𝗲 𝗺𝗼𝘀𝘁 𝘃𝗮𝗹𝘂𝗮𝗯𝗹𝗲 𝗖𝗗𝘅 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗲𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝘀𝗼𝘂𝗿𝗰𝗲𝘀, with a strong focus on image-based and digital learning. From PD-L1 to HER2 and beyond, these platforms are helping improve scoring consistency and accelerate access to targeted therapies. https://lnkd.in/grZd-uHm Curious to hear your perspective: Where do you see the biggest gap today in biomarker training? #DigitalPathology #Biomarkers #Oncology #PrecisionMedicine #IHC #PDL1 #HER2

𝗢𝗻𝗲 𝘁𝗵𝗶𝗻𝗴 𝗶𝘀 𝗳𝗼𝗿 𝘀𝘂𝗿𝗲... 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗶𝗻𝘁𝗲𝗿𝗽𝗿𝗲𝘁𝗮𝘁𝗶𝗼𝗻 𝗺𝘂𝘀𝘁 𝗯𝗲 𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝘁. But in clinical trials and daily routine pathologists often:  • work across multiple sites  • have different experience levels  • have or develop varying interpretation standards This variability in scoring can impact trial outcomes, biomarker validation and patient selection. PathoTrainer helps organizations standardize biomarker scoring through digital slide reference sets, expert led consensus scoring, and proficiency testing. This is not just a software platform, we have over 10 years of experience creating content and providing support for in clinical trials, biomarker validation, and global biomarker training programs. 𝗔𝘁 𝗣𝗮𝘁𝗵𝗼𝗺𝗮𝘁𝗶𝗼𝗻, 𝘄𝗲 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝘀 𝗮 𝗿𝗲𝗹𝗶𝗮𝗯𝗹𝗲 𝗽𝗮𝗿𝘁𝗻𝗲𝗿 𝗳𝗼𝗿 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘁𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗮𝗻𝗱 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝗶𝘇𝗮𝘁𝗶𝗼𝗻. Because precision medicine depends on reproducible pathology interpretation. More info: https://lnkd.in/gVApC9PH #DigitalPathology #Biomarkers #ClinicalTrials

𝗙𝗼𝗿 𝗺𝗮𝗻𝘆 𝗹𝗮𝗯𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗶𝗻𝗴 𝘁𝗵𝗲𝗶𝗿 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗮𝗿𝗼𝘂𝗻𝗱 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝘀𝗹𝗶𝗱𝗲 𝗶𝗺𝗮𝗴𝗲 𝗿𝗲𝘃𝗶𝗲𝘄 𝗶𝘀 𝘀𝘁𝗶𝗹𝗹 𝗮 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲. Pathologists still often deal with fragmented processes:  • a mix of digital slide images and physical glass slides due to scanner technical limitations or capacity  • difficult file formats requiring additional non-integrated viewers  • slide images shared via email or SharePoint that do not enter the regular workflow  • software that does not support all lab processes linked to digital pathology creating gaps in your daily routine Digital pathology becomes powerful when it supports 𝘁𝗵𝗲 𝗲𝗻𝘁𝗶𝗿𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄. In clinical labs, this means enabling:  • structured case management with automated real time slide image ingestion  • live visibility on staining and scanning status  • work from anywhere with anyone thanks to web-based slide access  • full end to end process support including image QC, diagnosing, case comments and annotations, review handovers, collaborative case review, remote consultations and second opinions Platforms like 𝗣𝗜𝗠𝗦𝗗𝗫 help labs move from scattered slide storage to a structured digital pathology workflow. Curious to see our solutions for diagnostic labs of all sizes? visit our website: https://lnkd.in/eFt8bGaa #DigitalPathology #Diagnostics #QC #Workflow

𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗲𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝗮𝗿𝗲 𝗯𝗲𝗰𝗼𝗺𝗶𝗻𝗴 𝗺𝗼𝗿𝗲 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲 𝗰𝗼𝗺𝗽𝗹𝗲𝘅. Today’s labs work with a growing mix of:  • scanners from different vendors  • multiple AI image analysis software  • LIS and Hospital IT systems And tomorrow, there will only be more. In such environments, 𝗳𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗺𝗮𝘁𝘁𝗲𝗿𝘀! Digital pathology platforms should allow labs to constantly evolve and integrate new technologies without being locked in. At Pathomation, openness and interoperability have always been core design principles. Let’s have a chat! https://lnkd.in/eJfXHBSC #Ecosystem #DigitalPathology #Interoperability

No, this is not confetti... Just AI analysing pathology slides. Each coloured marker represents an AI-detected cell classification across the tissue sample. AI in pathology is advancing rapidly but its real value appears when results can be reviewed directly inside the pathologist’s workflow. With the Pathomation AI Marketplace, laboratories can run and evaluate AI algorithms within their digital pathology environment, making it easier to integrate AI insights into routine workflows. Turns out pathology can be quite colourful when AI joins the workflow. More info? Have a look at our approach on AI in pathology here: https://lnkd.in/eh9HU95A #AIinPathology #workflow

The Future of Cancer Diagnostics is Cross-Border and Digital 🌍🖥️ Great energy at the #DigiPathConnect consortium meeting last week! Supported by Interreg Meuse-Rhine (NL-BE-DE), this project aims to push the boundaries of digital pathology and AI 🧬💻 This time, the meeting was hosted by Hasselt University at Embuild Limburg. From a digital pathology platform and advanced imaging, to AI-driven insights for oncology, our partners are making incredible progress: ▸ Maastricht University & M4i - Maastricht for Imaging ▸ University of Liège ▸ Uniklinik Köln ▸ Pathomation ▸ Aspect Analytics ▸ BIOMED-UHasselt & Data Science Institute (DSI) UHasselt By building a cross-border platform for sharing and analyzing pathology images, we aim to support collaboration between experts, speed up diagnostics, and develop new AI tools for diseases such as lung and colorectal cancer 🤝🌍 👉 Curious to learn more? Visit our project webpage: https://lnkd.in/eqiCruGk Esther Wolfs, Dirk Valkenborg, Sandrina Martens, Joachim Webers, Yuri Tolkach, Bide Zhang, Julian Westerdorf, Alexander Vingerhoets, Rudy Hovelinck, Nico Verbeeck, Raphaël Marée, Pierre Geurts, Maxime Amodei, Benjamin Balluff, Akash Singh Chauhan, Veerle Melotte #DigitalPathology #ArtificialIntelligence #AI #MassSpecImaging #Pathology #LungCancer #ColorectalCancer #Diagnostics #Oncology #interregmeuserhine #interreg #madewithinterreg #euinmyregion

𝗪𝗵𝗲𝗻 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝘄𝗼𝗿𝗸𝘀 𝘄𝗲𝗹𝗹, 𝘆𝗼𝘂 𝗯𝗮𝗿𝗲𝗹𝘆 𝗻𝗼𝘁𝗶𝗰𝗲 𝘁𝗵𝗲 𝘀𝗼𝗳𝘁𝘄𝗮𝗿𝗲. Whole Slide Image formats are complex, you want a cloud software platform where different image formats behave consistently in every aspect from uploading, viewing all the way to AI analysis. For pathologists and researchers working with whole slide images, that reliability makes the actual difference in daily workflows. The latest 𝗠𝘆 𝗣𝗮𝘁𝗵𝗼𝗺𝗮𝘁𝗶𝗼𝗻 release focuses on strengthening exactly that foundation. The software now actively guides users through uploads of complex file formats, DICOM images behave like any other file format, AI analysis workflows for Regions of Interest are now fully flexible. You will also notice many improvements suggested by our users that makes your digital pathology workflow smoother and more reliable. These updates also prepare the platform for upcoming new exiting capabilities for second opinion case sharing. 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮𝘁 𝗨𝗦𝗖𝗔𝗣? Grab your chance and meet Olivier at 𝗯𝗼𝗼𝘁𝗵 𝟮𝟯𝟰 for a first look at the new My Pathomation. #NewRelease #WSI #Collaboration #AIinPathology #USCAP